Chemoinformaics analysis of 1,3,12-Nonadecatriene
| Molecular Weight | 262.481 | nRot | 14 |
| Heavy Atom Molecular Weight | 228.209 | nRig | 3 |
| Exact Molecular Weight | 262.266 | nRing | 0 |
| Solubility: LogS | -6.959 | nHRing | 0 |
| Solubility: LogP | 8.167 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 54.401 |
| nHD | 0 | BPOL | 34.109 |
| QED | 0.18 |
| Synth | 2.488 |
| Natural Product Likeliness | 1.332 |
| NR-PPAR-gamma | 0.192 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.012 |
| Pgp-sub | 0.008 |
| HIA | 0.003 |
| CACO-2 | -4.743 |
| MDCK | 0.00000837 |
| BBB | 0.332 |
| PPB | 0.982458 |
| VDSS | 4.119 |
| FU | 0.0153227 |
| CYP1A2-inh | 0.729 |
| CYP1A2-sub | 0.196 |
| CYP2c19-inh | 0.489 |
| CYP2c19-sub | 0.169 |
| CYP2c9-inh | 0.236 |
| CYP2c9-sub | 0.956 |
| CYP2d6-inh | 0.453 |
| CYP2d6-sub | 0.739 |
| CYP3a4-inh | 0.67 |
| CYP3a4-sub | 0.1 |
| CL | 3.911 |
| T12 | 0.085 |
| hERG | 0.032 |
| Ames | 0.12 |
| ROA | 0.03 |
| SkinSen | 0.985 |
| Carcinogencity | 0.479 |
| EI | 0.952 |
| Respiratory | 0.759 |
| NR-Aromatase | 0.685 |
| Antiviral | Yes |
| Prediction | 0.574428 |